Related references
Note: Only part of the references are listed.Interleukin 8, a Biomarker to Differentiate Guillain-Barre Syndrome From CIDP
Gautier Breville et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
Evidence of altered Th17 pathway signatures in the cerebrospinal fluid of patients with Guillain Barre Syndrome
Monojit Debnath et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2020)
Ganglioside complex antibodies in an Indian cohort of Guillain-Barre syndrome
Rahul Wahatule et al.
MUSCLE & NERVE (2020)
Diagnosis and management of Guillain-Barre syndrome in ten steps
Sonja E. Leonhard et al.
NATURE REVIEWS NEUROLOGY (2019)
Peripheral Blood and Cerebrospina Fluid Cytokine Levels in Guillain Barre Syndrome: A Systematic Review and Meta-Analysis
Ting Sun et al.
FRONTIERS IN NEUROSCIENCE (2019)
Interleukin-33 gene expression and rs1342326 polymorphism in Behcet's disease
Mahsa Talei et al.
IMMUNOLOGY LETTERS (2019)
Novel protective mechanism for interleukin-33 at the mucosal barrier during influenza-associated bacterial superinfection
K. M. Robinson et al.
MUCOSAL IMMUNOLOGY (2018)
Comprehensive cytokine profiling provides evidence for a multi-lineage Th responses in Guillain Barre Syndrome
Monojit Debnath et al.
CYTOKINE (2018)
Male-specific IL-33 expression regulates sex-dimorphic EAE susceptibility
Abigail E. Russi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial
Ingemar S. J. Merkies et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM (2017)
The rs7044343 Polymorphism of the Interleukin 33 Gene Is Associated with Decreased Risk of Developing Premature Coronary Artery Disease and Central Obesity, and Could Be Involved in Regulating the Production of IL-33
Javier Angeles-Martinez et al.
PLOS ONE (2017)
Genetic variant in IL-33 is associated with idiopathic recurrent miscarriage in Chinese Han population
Jun Yue et al.
SCIENTIFIC REPORTS (2016)
Interleukin-33 ameliorates ischemic brain injury in experimental stroke through promoting Th2 response and suppressing Th17 response
Yi Luo et al.
BRAIN RESEARCH (2015)
Biomarkers of Guillain-Barre Syndrome: Some Recent Progress, More Still to Be Explored
Ying Wang et al.
MEDIATORS OF INFLAMMATION (2015)
Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria
Christiaan Fokke et al.
BRAIN (2014)
Mitigated Tregs and Augmented Th17 Cells and Cytokines are Associated with Severity of Experimental Autoimmune Neuritis
X. Wang et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2014)
Common genetic variation at the IL1RL1 locus regulates IL-33/ST2 signaling
Jennifer E. Ho et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Associations between Genetic Polymorphisms in IL-33, IL1R1 and Risk for Inflammatory Bowel Disease
Anna Latiano et al.
PLOS ONE (2013)
The Alarmin Interleukin-33 Drives Protective Antiviral CD8+ T Cell Responses
Weldy V. Bonilla et al.
SCIENCE (2012)
Primary sources and immunological prerequisites for sST2 secretion in humans
Michael Mildner et al.
CARDIOVASCULAR RESEARCH (2010)
Evaluation of candidate genes in a genome-wide association study of childhood asthma in Mexicans
Hao Wu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2010)
Elevated levels of soluble ST2 protein in dengue virus infected patients
Aniuska Becerra et al.
CYTOKINE (2008)
IL-33 amplifies both Th1-and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells
Molly D. Smithgall et al.
INTERNATIONAL IMMUNOLOGY (2008)
The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel 'Alarmin'?
Christine Moussion et al.
PLOS ONE (2008)
A clinical prognostic scoring system for Guillain-Barre syndrome
Rinske van Koningsveld et al.
LANCET NEUROLOGY (2007)
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
J Schmitz et al.
IMMUNITY (2005)